International Biotechnology (LON:IBT – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 646.39 ($8.28) and traded as high as GBX 666 ($8.53). International Biotechnology shares last traded at GBX 662 ($8.48), with a volume of 136,587 shares trading hands.
International Biotechnology Trading Up 0.9 %
The firm has a market cap of £273.98 million, a P/E ratio of 666.67 and a beta of 0.18. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.27 and a quick ratio of 0.32. The stock has a 50 day moving average of GBX 643.81 and a 200 day moving average of GBX 647.33.
International Biotechnology Increases Dividend
The company also recently announced a dividend, which will be paid on Friday, August 23rd. Investors of record on Thursday, July 25th will be paid a GBX 14.50 ($0.19) dividend. This represents a yield of 2.28%. The ex-dividend date of this dividend is Thursday, July 25th. This is a boost from International Biotechnology’s previous dividend of $13.90. International Biotechnology’s dividend payout ratio is currently 2,666.67%.
International Biotechnology Company Profile
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
See Also
- Five stocks we like better than International Biotechnology
- How to Invest in the FAANG Stocks
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Roth IRA Calculator: Calculate Your Potential Returns
- This Financial Stock’s Earnings Signal a Buying Opportunity
- What Are Trending Stocks? Trending Stocks Explained
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.